Abstract
Intravascular large B-cell lymphoma (IVLBCL) presents diagnostic challenges due to the absence of pathognomonic signs and symptoms, lack of lymphadenopathy, and the presence of nonspecific clinical manifestations such as fever of unknown origin, malaise, and anemia. Recognizing its diverse clinical presentations is essential for early diagnosis and improved patient outcomes. This retrospective study analyzed the presenting symptoms, clinical and laboratory findings, clinical course and treatment strategies in four patients diagnosed with IVLBCL at our institution over the past 15 years. All patients presented with fever of unknown origin, absence of lymphadenopathy, anemia, elevated serum ferritin, markedly increased levels of lactate dehydrogenase and β2-microglobulin, and monocytosis in three of the four cases. Neurological symptoms were also observed in three patients. Positron emission tomography (PET) showed bone marrow uptake in two of the three patients who underwent the scan; however, histologic confirmationof marrow involvement was found in only one case. In two patients, the diagnosis was established via random skin biopsy of clinically normal-appearing skin. Given the presence of fever of unknown origin, random skin biopsy should be considered, as it may facilitate early identification of IVLBCL. Increased awareness of the varied clinical presentations of IVLBCL can lead to earlier diagnosis and, consequently, better outcomes for these patients.
References
Murase T, Yamaguchi M, Suzuki R et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007;109(2):478-485.
Matsue K, Abe Y, Narita K et al. Diagnosis of intravascular large B cell lymphoma: novel insights into clinicopathological features from 42 patients at a single institution over 20 years. Br J Haematol.
;187(3):328-336.
Nakamura S, Ponzoni M, Campo E. lntravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL et al., (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th edition). International Agency for Research on Cancer (IARC); 2017: 319-320.
Ferreri AJ, Dognini GP, Campo E et al. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica. 2007;92(4):486-492.
Matsue K, Abe Y, Kitadate A et al. Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Blood. 2019;133(11):1257-1259.
Ponzoni M, Campo E, Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood. 2018;132(15):1561-1567.
Geer M, Roberts E, Shango M, Till BG, Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual JE, Boonstra PS, Devata S, Wilcox RA, Kaminski MS, Phillips TJ. Multicenter retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. British Journal of Haematology. 2019; 186(2): 255-262. 8. Pothen L, Aydin S, Camboni A, Hainaut P. Nephrotic syndrome without kidney injury revealing intravascular large B cell lymphoma. BMJ Case Rep. 2019;12(6):e229359.
Nguyen TT, Sekiguchi H, Yi ES, Ryu JH. Occult Diffuse Neoplasm in the Lungs: Intravascular Large B-Cell Lymphoma. American Journal of Medicine. 2021; 134(7): 926-9.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar
